These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


357 related items for PubMed ID: 15781736

  • 1. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
    Sackner-Bernstein JD, Skopicki HA, Aaronson KD.
    Circulation; 2005 Mar 29; 111(12):1487-91. PubMed ID: 15781736
    [Abstract] [Full Text] [Related]

  • 2. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL, Peng JT, Okamoto MP, Heywood JT.
    Ann Pharmacother; 2007 Apr 29; 41(4):556-61. PubMed ID: 17389662
    [Abstract] [Full Text] [Related]

  • 3. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.
    Circulation; 2004 Sep 21; 110(12):1620-5. PubMed ID: 15337695
    [Abstract] [Full Text] [Related]

  • 4. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S, Clarke K, Srinivasan V, Gradman A.
    QJM; 2007 Nov 21; 100(11):699-706. PubMed ID: 17971392
    [Abstract] [Full Text] [Related]

  • 5. Nesiritide: trials and tribulations.
    Arora RR.
    J Cardiovasc Pharmacol Ther; 2006 Sep 21; 11(3):165-9. PubMed ID: 17056828
    [Abstract] [Full Text] [Related]

  • 6. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL, Kurien S, Warfield KT, Wood CM, Jaffe AS.
    Int J Cardiol; 2008 May 23; 126(2):234-9. PubMed ID: 17482692
    [Abstract] [Full Text] [Related]

  • 7. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR, Johannes RS, Pine M, Gupta V, Saltzberg M, Hay J, Yancy CW, Fonarow GC.
    Am Heart J; 2007 Aug 23; 154(2):267-77. PubMed ID: 17643575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Short and long-term mortality with nesiritide.
    Arora RR, Venkatesh PK, Molnar J.
    Am Heart J; 2006 Dec 23; 152(6):1084-90. PubMed ID: 17161057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Xiong B, Wang C, Yao Y, Huang Y, Tan J, Cao Y, Zou Y, Huang J.
    PLoS One; 2015 Dec 23; 10(6):e0131326. PubMed ID: 26107522
    [Abstract] [Full Text] [Related]

  • 13. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH, Nazeer S, Pepe P, Estes B, Gorman A, Yancy CW.
    Ann Emerg Med; 2008 May 23; 51(5):571-8. PubMed ID: 18304693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
    Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O'Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL.
    Pediatr Crit Care Med; 2008 May 23; 9(3):279-84. PubMed ID: 18446113
    [Abstract] [Full Text] [Related]

  • 16. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.
    N Engl J Med; 2011 Jul 07; 365(1):32-43. PubMed ID: 21732835
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D, Burger AJ.
    Am Heart J; 2004 Nov 07; 148(5):e16. PubMed ID: 15523294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.